| Literature DB >> 31734363 |
João Xavier da Silva Neto1, Helen Paula Silva da Costa1, Ilka Maria Vasconcelos1, Mirella Leite Pereira2, Jose Tadeu Abreu Oliveira1, Tiago Deiveson Pereira Lopes1, Lucas Pinheiro Dias1, Nadine Monteiro Salgueiro Araújo1, Luiz Francisco Wemmenson Gonçalves Moura3, Mauricio Fraga Van Tilburg3, Maria Izabel Florindo Guedes3, Larissa Alves Lopes1, Eva Gomes Morais1, Daniele de Oliveira Bezerra de Sousa4.
Abstract
Plant proteins are emerging as an alternative to conventional treatments against candidiasis. The aim of this study was to better understand the mechanism of action of Mo-CBP2 against Candida spp, evaluating redox system activity, lipid peroxidation, DNA degradation, cytochrome c release, medium acidification, and membrane interaction. Anti-candida activity of Mo-CBP2 decreased in the presence of ergosterol, which was not observed with antioxidant agents. C. albicans treated with Mo-CBP2 also had catalase and peroxidase activities inhibited, while superoxide dismutase was increased. Mo-CBP2 increased the lipid peroxidation, but it did not alter the ergosterol profile in live cells. External medium acidification was strongly inhibited, and cytochrome c release and DNA degradation were detected. Mo-CBP2 interacts with cell membrane constituents, changes redox system enzymes in C. albicans and causes lipid peroxidation by ROS overproduction. DNA degradation and cytochrome c release suggest apoptotic or DNAse activity. Lipid peroxidation and H+-ATPases inhibition may induce the process of apoptosis. Finally, Mo-CBP2 did not have a cytotoxic effect in mammalian Vero cells. This study highlights the biotechnological potential of Mo-CBP2 as a promising molecule with low toxicity and potent activity. Further studies should be performed to better understand its mode of action and toxicity.Entities:
Year: 2019 PMID: 31734363 DOI: 10.1016/j.ijbiomac.2019.09.142
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953